Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Armand

Showing results (231-240 of 240) with videos related to

Pageof 24
Sort By:
You have reached the last page of results.This site can display upto 240 results.
Bone Marrow Transplantation|May 22, 2012
Pre-transplantation iron chelation in patients with MDS or acute leukemia and iron overload undergoing myeloablative allo-SCTP Armand, M-M Sainvil, H T Kim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 29, 1998
Recombinant human erythropoietin in the treatment of chemotherapy-induced anemia and prevention of transfusion requirement associated with solid tumors: a randomized, controlled studyC Oberhoff, B Neri, D Amadori, et al.
Leukemia|September 8, 2012
Long-term follow-up of reduced-intensity allogeneic stem cell transplantation for chronic lymphocytic leukemia: prognostic model to predict outcomeJ R Brown, H T Kim, P Armand, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 1998
Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patientsR De Crevoisier, J Bourhis, C Domenge, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2000
A dose-finding study of gemcitabine and vinorelbine in advanced previously treated malignanciesJ P Delord, E Raymond, M Chaouche, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 28, 2002
Population pharmacokinetics of the novel anticancer agent E7070 during four phase I studies: model building and validationCh Van Kesteren, R A A Mathôt, E Raymond, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 16, 2011
Sequential research-related biopsies in phase I trials: acceptance, feasibility and safetyC A Gomez-Roca, L Lacroix, C Massard, et al.
Bone Marrow Transplantation|August 11, 2010
Double umbilical cord blood transplantation with reduced intensity conditioning and sirolimus-based GVHD prophylaxisC Cutler, K Stevenson, H T Kim, et al.
Leukemia|July 4, 2015
Phase I/II trial of everolimus in combination with bortezomib and rituximab (RVR) in relapsed/refractory Waldenstrom macroglobulinemiaI M Ghobrial, R Redd, P Armand, et al.
European Journal of Cancer (Oxford, England : 1990)|January 15, 2016
Immune-related adverse events with immune checkpoint blockade: a comprehensive reviewJ M Michot, C Bigenwald, S Champiat, et al.
Pageof 24

Showing results (231-240 of 240) with videos related to

Sort By:
Pageof 24
You have reached the last page of results.This site can display upto 240 results.
Bone Marrow Transplantation|May 22, 2012
Pre-transplantation iron chelation in patients with MDS or acute leukemia and iron overload undergoing myeloablative allo-SCTP Armand, M-M Sainvil, H T Kim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 29, 1998
Recombinant human erythropoietin in the treatment of chemotherapy-induced anemia and prevention of transfusion requirement associated with solid tumors: a randomized, controlled studyC Oberhoff, B Neri, D Amadori, et al.
Leukemia|September 8, 2012
Long-term follow-up of reduced-intensity allogeneic stem cell transplantation for chronic lymphocytic leukemia: prognostic model to predict outcomeJ R Brown, H T Kim, P Armand, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 1998
Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patientsR De Crevoisier, J Bourhis, C Domenge, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2000
A dose-finding study of gemcitabine and vinorelbine in advanced previously treated malignanciesJ P Delord, E Raymond, M Chaouche, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 28, 2002
Population pharmacokinetics of the novel anticancer agent E7070 during four phase I studies: model building and validationCh Van Kesteren, R A A Mathôt, E Raymond, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 16, 2011
Sequential research-related biopsies in phase I trials: acceptance, feasibility and safetyC A Gomez-Roca, L Lacroix, C Massard, et al.
Bone Marrow Transplantation|August 11, 2010
Double umbilical cord blood transplantation with reduced intensity conditioning and sirolimus-based GVHD prophylaxisC Cutler, K Stevenson, H T Kim, et al.
Leukemia|July 4, 2015
Phase I/II trial of everolimus in combination with bortezomib and rituximab (RVR) in relapsed/refractory Waldenstrom macroglobulinemiaI M Ghobrial, R Redd, P Armand, et al.
European Journal of Cancer (Oxford, England : 1990)|January 15, 2016
Immune-related adverse events with immune checkpoint blockade: a comprehensive reviewJ M Michot, C Bigenwald, S Champiat, et al.
Pageof 24